A61P 11/06
Antiasthmatics
A61P11/06 (Antiasthmatics) appears on 15,715 US grants and 23,581 published applications in this corpus.
Search patents in A61P- Granted patents
- 15,715
- Published applications
- 23,581
- Assignees
- 4,578
- Inventors
- 31,640
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 5 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 1 | 0 |
| 1980 | 2 | 0 |
| 1981 | 3 | 0 |
| 1982 | 3 | 0 |
| 1983 | 2 | 0 |
| 1984 | 4 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 4 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 3 | 0 |
| 1991 | 3 | 0 |
| 1992 | 3 | 0 |
| 1993 | 12 | 0 |
| 1994 | 18 | 0 |
| 1995 | 29 | 0 |
| 1996 | 37 | 0 |
| 1997 | 78 | 0 |
| 1998 | 76 | 0 |
| 1999 | 149 | 0 |
| 2000 | 211 | 0 |
| 2001 | 307 | 76 |
| 2002 | 384 | 514 |
| 2003 | 401 | 956 |
| 2004 | 329 | 1251 |
| 2005 | 407 | 1208 |
| 2006 | 513 | 1182 |
| 2007 | 583 | 1316 |
| 2008 | 611 | 1401 |
| 2009 | 771 | 1629 |
| 2010 | 930 | 1816 |
| 2011 | 993 | 1630 |
| 2012 | 1135 | 1583 |
| 2013 | 1176 | 1117 |
| 2014 | 1089 | 1174 |
| 2015 | 866 | 1044 |
| 2016 | 756 | 976 |
| 2017 | 784 | 835 |
| 2018 | 651 | 793 |
| 2019 | 577 | 669 |
| 2020 | 484 | 566 |
| 2021 | 387 | 458 |
| 2022 | 268 | 380 |
| 2023 | 207 | 323 |
| 2024 | 188 | 297 |
| 2025 | 176 | 234 |
| 2026 | 97 | 153 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods of identifying and evaluating cat allergy gene signatures in a subject by determining a stratified score based on gene expression29 Sep 2026US 12,747,287 B2Regeneron Pharmaceuticals, Inc.
- Pharmaceutical composition containing antibody against IL-5 and use thereof22 Sep 2026US 12,742,004 B2Jiangsu Hengrui Medicine Co., Ltd.
- Calixarene compounds and uses thereof25 Aug 2026US 12,714,682 B2Universität Wien
- Methods for preventing an immunoglobulin e-related disease25 Aug 2026US 12,714,736 B2My-Or Diagnostics Ltd.
- Molecules18 Aug 2026US 12,709,596 B2Ena Respiratory Pty Ltd
- Mixture of hmos and b. infantis8 Oct 2026US 2026/0306563 A1Societe des Produits Nestle S. A.
- Mixture of hmos and b. infantis8 Oct 2026US 2026/0306564 A1Societe des Produits Nestle S. A.
- Method for producing the subunits of human interleukin 35 from interleukin 12 and interleukin 2724 Sep 2026US 2026/0285930 A1Technische Universitaet Muenchen, in Vertretung des Freistaates Bayern
- Asthma treatment by blocking il-13 and tslp24 Sep 2026US 2026/0285965 A1Sanofi
- Treatment And Inhibition Of Inflammatory Lung Diseases In Patients Having Risk Alleles In The Genes Encoding IL33 And IL1RL124 Sep 2026US 2026/0285990 A1Regeneron Pharmaceuticals, Inc.
Most cited
By later US patents
- (20S)-1α-hydroxy-2α-methyl and 2β-methyl-19-nor-vitamin D3 and their uses1,031US 7,094,916 B2Wisconsin Alumni Research Foundation · 2006
- Immunostimulatory nucleic acid molecules472US 6,207,646 B1Coley Pharmaceutical Group, Inc. · 2001
- Immunostimulatory nucleic acid molecules461US 6,239,116 B1Coley Pharmaceutical Group, Inc. · 2001
- Dual variable domain immunoglobulin and uses thereof391US 7,612,181 B2Abbott Laboratories · 2009
- Polypeptide variants with altered effector function381US 7,371,826 B2Genentech, Inc. · 2008